Tumor-related mechanistic studies have shown that Morrbid promotes tumorigenesis, progression, and drug resistance by altering the biological behavior of tumor cells, affecting cell survival, and altering cellular metabolism. The gene discussed is MIR4435-2HG; the disease is neoplasm.